DSP Healthcare Fund Direct Growth
EquitySector - Healthcare
43.62
-0.19(-0.43%)
NAV as on 12 Dec, 2025
CAGR
22.55%
- AUM (Crs.)3,178.53
- Expense Ratio0.56 %
- Sharpe Ratio / Category Average1.03 / 0.94
- Standard Deviation / Category Average14.61 / 16.00
- Beta / Category Average0.84 / 0.96
- Portfolio Turnover / Category Average19.26 / 56.14
- Top 5 Stocks Wt.38.33
- Top 10 Stocks Wt.64.11
- Top 3 Sectors Wt.97.06
- Investment StyleMid Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocks--
- Avg. Market Cap--
- Top 10 Stocks--
- Top 5 Stocks--
- Top 3 Sectors--
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistoryChirag Dagli
- Launch Date30 Nov, 2018
- BenchmarkS&P BSE 500
Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|